Sapience Investments, LLC / IART
Sapience Investments, LLC’s Integra Lifesciences Hldgs C Position
Does Sapience Investments, LLC own Integra Lifesciences Hldgs C (IART)? Yes — 1.9K shares worth $18,030 (+2.34% of its 13F portfolio) as of Q1 2026, down from 47.4K shares the prior filed quarter.
Position Value
$18,030
Q1 2026
Shares
1.9K
% of Portfolio
+2.34%
Quarters Held
29
currently held
Position History IART
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.9K | $18,030 | +2.34% |
| Q4 2025 | 47.4K | $588,484 | +2.22% |
| Q3 2025 | 40.0K | $573,157 | +2.25% |
| Q2 2025 | 219.0K | $3M | +1.79% |
| Q1 2025 | 142.8K | $3M | +2.24% |
| Q4 2024 | 164.8K | $4M | +2.18% |
| Q3 2024 | 139.9K | $3M | +1.26% |
| Q2 2024 | 140.2K | $4M | +2.09% |
| Q1 2024 | 155.8K | $6M | +1.83% |
| Q4 2023 | 231.1K | $10M | +2.40% |
| Q3 2023 | 245.7K | $9M | +2.26% |
| Q2 2023 | 224.2K | $9M | +2.07% |
| Q1 2023 | 192.6K | $11M | +2.56% |
| Q4 2022 | 203.8K | $11M | +2.40% |
| Q3 2022 | 257.1K | $11M | +2.29% |
| Q2 2022 | 165.1K | $9M | +1.67% |
| Q1 2022 | 197.4K | $13M | +1.54% |
| Q4 2021 | 205.4K | $14M | +1.57% |
| Q3 2021 | 177.6K | $12M | +1.44% |
| Q2 2021 | 161.7K | $11M | +1.37% |
| Q1 2021 | 169.3K | $12M | +1.47% |
| Q4 2020 | 248.6K | $16M | +2.24% |
| Q3 2020 | 266.9K | $13M | +2.24% |
| Q2 2020 | 212.7K | $10M | +1.84% |
| Q1 2020 | 273.1K | $12M | +2.71% |
| Q4 2019 | 254.2K | $15M | +2.07% |
| Q3 2019 | 163.5K | $10M | +1.37% |
| Q2 2019 | 163.8K | $9M | +1.25% |
| Q1 2019 | 132.8K | $7M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sapience Investments, LLC’s full portfolio or all institutional holders of IART.